Skip to main navigation Skip to search Skip to main content

Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis

  • Mark J. Taylor
  • , Thomas W. Von Geldern
  • , Louise Ford
  • , Marc P. Hübner
  • , Kennan Marsh
  • , Kelly L. Johnston
  • , Hanna T. Sjoberg
  • , Sabine Specht
  • , Nicolas Pionnier
  • , Hayley E. Tyrer
  • , Rachel H. Clare
  • , Darren A.N. Cook
  • , Emma Murphy
  • , Andrew Steven
  • , John Archer
  • , Dominique Bloemker
  • , Franziska Lenz
  • , Marianne Koschel
  • , Alexandra Ehrens
  • , Haelly M. Metuge
    • Valerinne C. Chunda, Patrick W.Ndongmo Chounna, Abdel J. Njouendou, Fanny F. Fombad, Robert Carr, Howard E. Morton, Ghaith Aljayyoussi, Achim Hoerauf, Samuel Wanji, Dale J. Kempf, Joseph D. Turner, Stephen A. Ward*
*Corresponding author for this work
  • Liverpool School of Tropical Medicine
  • AbbVie
  • Franciscan University of Steubenville
  • University of Bonn
  • Research Centre for Drugs and Diagnostics
  • Research Foundation for Tropical Diseases and the Environment
  • University of Buea

Research output: Contribution to journal › Article (journal) › peer-review

72   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases